PAR 5.36% 29.5¢ paradigm biopharmaceuticals limited..

So all of you can do your math if the n should be 640 patients...

  1. 548 Posts.
    lightbulb Created with Sketch. 220
    So all of you can do your math if the n should be 640 patients treated / jabbed in 2023

    So $41m / 640 = $64k per patient, which is A$19.2m if they only need to treat 300 is stage 2.




 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.